DE69627195D1 - Purinderivate und verfahren zu ihrer herstellung - Google Patents
Purinderivate und verfahren zu ihrer herstellungInfo
- Publication number
- DE69627195D1 DE69627195D1 DE69627195T DE69627195T DE69627195D1 DE 69627195 D1 DE69627195 D1 DE 69627195D1 DE 69627195 T DE69627195 T DE 69627195T DE 69627195 T DE69627195 T DE 69627195T DE 69627195 D1 DE69627195 D1 DE 69627195D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- purine derivatives
- purine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH309495 | 1995-11-01 | ||
CH221396 | 1996-09-10 | ||
PCT/EP1996/004573 WO1997016452A1 (en) | 1995-11-01 | 1996-10-22 | Purine derivatives and processes for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69627195D1 true DE69627195D1 (de) | 2003-05-08 |
DE69627195T2 DE69627195T2 (de) | 2004-01-29 |
Family
ID=25689809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69627195T Expired - Lifetime DE69627195T2 (de) | 1995-11-01 | 1996-10-22 | Purinderivate und verfahren zu ihrer herstellung |
Country Status (14)
Country | Link |
---|---|
US (1) | US7091346B1 (de) |
EP (1) | EP0874846B1 (de) |
JP (2) | JP4004066B2 (de) |
CN (1) | CN1066147C (de) |
AR (1) | AR004134A1 (de) |
AT (1) | ATE236161T1 (de) |
AU (1) | AU7296896A (de) |
BR (1) | BR9611157A (de) |
CA (1) | CA2234609C (de) |
DE (1) | DE69627195T2 (de) |
ES (1) | ES2196181T3 (de) |
HK (1) | HK1016580A1 (de) |
PT (1) | PT874846E (de) |
WO (1) | WO1997016452A1 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6794390B2 (en) * | 1996-08-02 | 2004-09-21 | Cv Therapeutics, Inc. | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
AU4920397A (en) * | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
US6573044B1 (en) | 1997-08-07 | 2003-06-03 | The Regents Of The University Of California | Methods of using chemical libraries to search for new kinase inhibitors |
US6255485B1 (en) | 1997-08-07 | 2001-07-03 | The Regents Of The University Of California | Purine inhibitors of protein kinases, G proteins and polymerases |
EE200000289A (et) | 1997-10-27 | 2001-06-15 | Agouron Pharmaceuticals, Inc. | Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid |
WO1999031072A1 (en) * | 1997-12-18 | 1999-06-24 | E.I. Du Pont De Nemours And Company | Cyclohexylamine arthropodicides and fungicides |
CA2320448C (en) * | 1998-02-26 | 2005-02-01 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines |
KR100568657B1 (ko) * | 1998-02-26 | 2006-04-07 | 아벤티스 파마슈티칼스 인크 | 6,9-이치환 2-[트랜스-(4-아미노시클로헥실)아미노]퓨린 |
US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
US6642231B2 (en) * | 1998-02-26 | 2003-11-04 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
CZ27399A3 (cs) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
JP2003519232A (ja) * | 2000-01-07 | 2003-06-17 | ウニフェルジテーレ・インステリング・アントウェルペン | プリン誘導体、その製造法およびその使用 |
WO2001082967A1 (en) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | MEDICINAL COMPOSITIONS FOR SUPPRESSING β-AMYLOID PRODUCTION |
US6861524B2 (en) | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
FR2818642B1 (fr) | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
GB2378180B8 (en) | 2001-06-27 | 2009-10-21 | Cyclacel Ltd | New purine derivatives |
WO2003013540A1 (en) * | 2001-08-10 | 2003-02-20 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
WO2003031406A2 (en) * | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
GB0219052D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
DE60318321T2 (de) * | 2002-09-19 | 2008-12-11 | Schering Corp. | Pyrazolopyridine als hemmstoffe cyclin abhängiger kinasen |
US7273864B2 (en) * | 2002-10-15 | 2007-09-25 | The Scripps Research Institute | Compositions and methods for inducing osteogenesis |
JP2006521398A (ja) | 2003-03-28 | 2006-09-21 | サイオス・インコーポレーテツド | TGFβの二−環式ピリミジン阻害剤 |
US20050288290A1 (en) * | 2004-06-28 | 2005-12-29 | Borzilleri Robert M | Fused heterocyclic kinase inhibitors |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
WO2007070872A1 (en) | 2005-12-15 | 2007-06-21 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
EP2091918B1 (de) * | 2006-12-08 | 2014-08-27 | Irm Llc | Verbindungen und zusammensetzungen als proteinkinase-hemmer |
BRPI0722384A2 (pt) | 2006-12-08 | 2012-06-12 | Irm Llc | compostos inibidores de proteÍna quinase, composiÇÕes contendo os mesmos bem como seus usos |
BRPI0808746B8 (pt) * | 2007-03-28 | 2021-05-25 | Neurosearch As | derivado de purinila como modulador do canal de potássio, composição farmacêutica, e, uso de um derivado de purinila. |
MX2009010122A (es) | 2007-03-28 | 2009-10-19 | Neurosearch As | Derivados de purinilo y su uso como moduladores del canal de potasio. |
CZ302225B6 (cs) * | 2007-07-04 | 2010-12-29 | Univerzita Palackého v Olomouci | Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny |
WO2009126515A1 (en) * | 2008-04-07 | 2009-10-15 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US8268838B2 (en) | 2008-09-26 | 2012-09-18 | Neurosearch A/S | Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators |
US20110237607A1 (en) * | 2008-09-26 | 2011-09-29 | Neurosearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
US10952415B2 (en) | 2011-03-09 | 2021-03-23 | Richard G. Pestell | Prostate cancer cell lines, gene signatures and uses thereof |
EP2822935B1 (de) | 2011-11-17 | 2019-05-15 | Dana-Farber Cancer Institute, Inc. | Inhibitoren der c-jun-n-terminal-kinase (jnk) |
JP6518585B2 (ja) | 2012-05-14 | 2019-05-22 | リチャード ジー. ペステル | がんの治療のためのccr5の修飾薬の使用 |
JP6223443B2 (ja) | 2012-06-26 | 2017-11-01 | サニオナ・エイピイエス | フェニルトリアゾール誘導体及びgabaa受容体複合体を調節するための該フェニルトリアゾール誘導体の使用 |
JP6170613B2 (ja) * | 2013-03-27 | 2017-07-26 | ジ アサン ファウンデーション | p34の発現抑制剤または活性抑制剤を有効成分で含む癌の治療または転移抑制用組成物 |
CN105849099B (zh) | 2013-10-18 | 2020-01-17 | 达纳-法伯癌症研究所股份有限公司 | 周期蛋白依赖性激酶7(cdk7)的多环抑制剂 |
EP3194572B1 (de) | 2014-07-30 | 2023-10-25 | Yeda Research and Development Co. Ltd. | Medien zur kultivierung pluripotenter stammzellen |
CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
EP3273966B1 (de) | 2015-03-27 | 2023-05-03 | Dana-Farber Cancer Institute, Inc. | Hemmer von cyclinabhängigen kinasen |
CA2996978A1 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
CN109937039A (zh) * | 2016-09-30 | 2019-06-25 | 斯坦福国际研究院 | 用于癌症治疗的双重clk/cdk1抑制剂 |
EP3914698A1 (de) | 2019-01-23 | 2021-12-01 | Yeda Research and Development Co. Ltd | Kulturmedien für pluripotente stammzellen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3529497A1 (de) | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
EP0457773A4 (en) | 1989-01-31 | 1993-03-10 | Whitby Research Incorporated | N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists |
US5663154A (en) * | 1992-01-06 | 1997-09-02 | Glaxo Wellcome Inc. | 2',3'-dideoxy-3'-fluoro-purine ribonucleosides |
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US5753635A (en) | 1996-08-16 | 1998-05-19 | Berlex Laboratories, Inc. | Purine derivatives and their use as anti-coagulants |
AU4920397A (en) | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
WO2003031406A2 (en) * | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
US7273864B2 (en) * | 2002-10-15 | 2007-09-25 | The Scripps Research Institute | Compositions and methods for inducing osteogenesis |
-
1996
- 1996-10-22 CN CN96198457.0A patent/CN1066147C/zh not_active Expired - Fee Related
- 1996-10-22 JP JP50604797A patent/JP4004066B2/ja not_active Expired - Fee Related
- 1996-10-22 AU AU72968/96A patent/AU7296896A/en not_active Abandoned
- 1996-10-22 EP EP96934774A patent/EP0874846B1/de not_active Expired - Lifetime
- 1996-10-22 CA CA002234609A patent/CA2234609C/en not_active Expired - Fee Related
- 1996-10-22 ES ES96934774T patent/ES2196181T3/es not_active Expired - Lifetime
- 1996-10-22 DE DE69627195T patent/DE69627195T2/de not_active Expired - Lifetime
- 1996-10-22 AT AT96934774T patent/ATE236161T1/de not_active IP Right Cessation
- 1996-10-22 PT PT96934774T patent/PT874846E/pt unknown
- 1996-10-22 BR BR9611157A patent/BR9611157A/pt not_active Application Discontinuation
- 1996-10-22 WO PCT/EP1996/004573 patent/WO1997016452A1/en active IP Right Grant
- 1996-10-22 US US09/051,827 patent/US7091346B1/en not_active Expired - Fee Related
- 1996-10-30 AR ARP960104961A patent/AR004134A1/es unknown
-
1999
- 1999-04-08 HK HK99101415A patent/HK1016580A1/xx not_active IP Right Cessation
-
2007
- 2007-06-05 JP JP2007148965A patent/JP2007231023A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1066147C (zh) | 2001-05-23 |
WO1997016452A1 (en) | 1997-05-09 |
CA2234609C (en) | 2006-11-28 |
ATE236161T1 (de) | 2003-04-15 |
AU7296896A (en) | 1997-05-22 |
CN1202896A (zh) | 1998-12-23 |
JP4004066B2 (ja) | 2007-11-07 |
AR004134A1 (es) | 1998-09-30 |
CA2234609A1 (en) | 1997-05-09 |
US7091346B1 (en) | 2006-08-15 |
HK1016580A1 (en) | 1999-11-05 |
EP0874846A1 (de) | 1998-11-04 |
DE69627195T2 (de) | 2004-01-29 |
BR9611157A (pt) | 1999-03-30 |
JPH11514336A (ja) | 1999-12-07 |
PT874846E (pt) | 2003-08-29 |
JP2007231023A (ja) | 2007-09-13 |
ES2196181T3 (es) | 2003-12-16 |
EP0874846B1 (de) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69627195T2 (de) | Purinderivate und verfahren zu ihrer herstellung | |
DE59602652D1 (de) | Zahnbürste und verfahren zu ihrer herstellung | |
DE59606535D1 (de) | Furnacerusse und Verfahren zu ihrer Herstellung | |
DE69616717D1 (de) | Berührungssensoren und verfahren zu ihrer herstellung | |
DE69530989D1 (de) | Neue pyrimidinderivate und verfahren zu ihrer herstellung | |
DE69624457D1 (de) | ArOMATIsIERTE PRODUKTE UND VERFAHREN ZU IHRER HERSTELLUNG | |
ATA902992A (de) | Antigeschwulstmittel und verfahren zu ihrer herstellung | |
DE69729128D1 (de) | Taxoid-derivate und verfahren zu ihrer herstellung | |
DE69211697D1 (de) | Antischmelzsicherungsstruktur und verfahren zu ihrer herstellung | |
DE69825960D1 (de) | In 2-position substituierte 7-haloindene und verfahren zu ihrer herstellung | |
DE69615668T2 (de) | O-carbamoyl-(d)-phenylalanilolverbindungen und verfahren zu ihrer herstellung. | |
DE69608359T2 (de) | Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung | |
DE69433296D1 (de) | Eisen-lactoferrin kombination und verfahren zu ihrer herstellung | |
DE69625176D1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung | |
DE69510774D1 (de) | Katschukzusammensetzung und verfahren zu ihrer herstellung | |
DE69622368D1 (de) | Schwefelverbindungen und verfahren zu ihrer herstellung | |
DE69626009T2 (de) | Pyrrolidinylhydroxamsäuren und verfahren zu ihrer herstellung | |
DE69801795T2 (de) | Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung | |
DE69614524D1 (de) | Etherverbindungen und verfahren zu ihrer herstellung | |
DE69523571T2 (de) | Pyridylimidazol-derivate und verfahren zu ihrer herstellung | |
DE69527445D1 (de) | Aminooligosaccharid-derivate und verfahren zu ihrer herstellung | |
DE69528586D1 (de) | Imidazolderivate und verfahren zu ihrer herstellung | |
DE69609986D1 (de) | Bitumenzusammensetzungen und verfahren zu ihrer herstellung | |
DE69603746T2 (de) | Bitumenzusammensetzungen und verfahren zu ihrer herstellung | |
DE69718308T2 (de) | 4-fluorsalicylsäurederivate und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |